Institutional HoldersBeta

Who holds a company, from every 13F filed for the quarter, one row per filer exactly as filed, against the latest share count the company reported.

Zivo Bioscience, Inc.

CIK 0001101026ZIVO· quarter ending 2026-06-30

Shares outstanding

3,888,595

as of 2025-11-09 · 10-Q cover page, filed 2025-11-14

Held by 13F filers

4,360

0.1% of shares outstanding

Holders

-1 vs 2026-03-31 · 0 new, 1 exited

Value

$18K

shares -2.3% vs prior quarter

Share classes (cover page of the 10-Q filed 2025-11-14, as of 2025-11-09)

Class	Listed	Shares outstanding	Held by 13F filers	% of class	Holders	CUSIP
Common stock	ZIVO	3,888,595	4,360	0.1%	1	98978N309

Each class is compared with its own share count; classes are not added together. A class that is not exchange-listed cannot be held by 13F filers.

Securities (CUSIPs held in 13F this quarter)

tick to combine

Count	CUSIP	Class (as filers write it)	Holders	Shares held	Class shares	% of class	Value	Options	Mapped via
	98978N309	Stock	1	4,360	3,888,595	0.1%	$18K	—	prefix	holders →

Totals combine the ticked CUSIPs and update as you tick: common-stock classes by default; preferreds, notes, warrants and depositary shares are listed but not counted. "holders →" shows a single CUSIP on its own. Bonds are held as a principal amount, not shares. Options positions are never counted as holdings. 3 further CUSIPs map to this company (mostly bonds) but no 13F filer held them this quarter.

Top holders (1 of 1 · 98978N309)

change vs 2026-03-31

#	Filer	Shares	% of class	Value	Change
1	CoreCap Advisors, LLC	4,360	0.11%	$18K	—

Exited since 2026-03-31 (1 filers; largest 1 shown)

HUNTINGTON NATIONAL BANK

−104

Large holders from 13D/13G (latest per reporting person, last 2 years)

Filed when a holder crosses 5% or changes materially, so often more current than the quarter-end 13F. Percentages are the filer's own, against the share count they used.

Reporting person	Form	Filed	Event	Shares	% of class
Mark E. Strome	SCHEDULE 13D/A	2026-02-27	2025-12-31	472,942	12.1%
Strome Group, Inc.	SCHEDULE 13D/A	2026-02-27	2025-12-31	278,639	7.13%
Strome Investment Management, LP	SCHEDULE 13D/A	2026-02-27	2025-12-31	278,639	7.13%
Strome Mezzanine Fund II, LP	SCHEDULE 13D/A	2026-02-27	2025-12-31	266,198	6.81%
Strome Mezzanine Fund, LP	SCHEDULE 13D/A	2026-02-27	2025-12-31	0	0%

Source: SEC Form 13F-HR information tables for the quarter ending 2026-06-30 (filed within 45 days of quarter end; amendments applied; values normalised to dollars), the share count from the company's latest 10-K/10-Q XBRL cover page, and Schedule 13D/13G filings. Each row is a legal 13F filer as filed — related entities (e.g. Vanguard's advisers) are not merged. Retail brokerage accounts are not reported on 13F, so the remainder is mostly retail and insiders.